PARIS – Ganymed Robotics SAS reported the successful completion of functional prototype testing for its surgical robotic assistant used in total knee arthroplasty. According to a systematic review of the literature, published in the Journal of Arthroplasty, more than 2 million patients undergo knee arthroplasty each year after suffering arthritis of the knee.
KARACHI, Pakistan – Pakistan is taking steps to produce coronary stents domestically as a way to improve the delivery of health care at home and, perhaps, tap into a growing global market.
N-ovative Health Technologies Pvt. Ltd., spun out of the National University of Science and Technology (NUST), started mass production of cardiac stents and angioplasty balloon catheters in October. It is the first such manufacturing facility in the country.
TORONTO – Biomaterials med-tech company 3D Biofibr Inc. has raised CA$550,000 (US$423,500) seed funding to develop, commercialize and scale up a biofilm platform that mimics the spinning behavior of the common spider.
TORONTO – What’s the difference between an organ transplant container tucked under a paramedic’s arm and an ordinary beer cooler packed with ice? Surprisingly, not much, according to researchers at London, Ontario’s Western University. They’ve come up with a portable, temperature-controlled container that prevents spoilage of donor organs during transport to the operating room – and of potential vaccines.
Spectrawave Inc. has named Eman Namati as its CEO with the charge of commercializing its flagship cardiac imaging technology. The 3-year-old, Bedford, Mass.-based medical imaging company has set an ambitious 24-month timeline for getting its photonic imaging technology for coronary artery disease into the clinic.
PARIS – Gleamer SAS has secured $8.75 million in series A financing for its CE-marked artificial intelligence (AI) application that automatically detects all types of fracture in radiography. “This funding will allow us to move forward with launching Boneview around the world,” Christian Allouche, CEO and co-founder of Gleamer, told BioWorld.
Israeli startup Olive Diagnostics Pvt. Ltd. is aiming to disrupt at-home urinalysis testing with a hands-free, noninvasive, artificial intelligence (AI)-based solution that provides remote diagnostics by detecting urine’s molecular composition. K2, as the device is called, attaches easily to the toilet rim to generate secure, personalized diagnostic data that directly links to a mobile app.
PERTH, Australia – After its initial public offering on the Australian Securities Exchange, soft tissue regeneration company Aroa Biosurgery Ltd. has received new clearances in the U.S. and Europe and is focusing on building up its commercial and manufacturing capacity.
Neuroone Medical Technology Corp.’s thin film, high definition cortical electrode technology, Evo, can record, monitor, ablate, and stimulate brain tissue for up to 30 days, potentially transforming neurosurgical procedures used to treat epilepsy, Parkinson’s disease, chronic pain, and other conditions.